Wednesday, November 4, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleMIT Technology Review

A startup claims it’s found a drug to make your blood young

View original at technologyreview.com
MIT Technology Review - Ai Research Title: A startup claims it’s found a drug to make your blood young Date: 2026-08-27 19:48 Source: https://www.technologyreview.com/2026/08/27/1143037/startup-claims-its-found-a-drug-to-make-your-blood-young/ <div></div> <p>I knew I’d officially become a ‘longevity influencer’ this mo…
Opening lines of the source · MIT Technology Review · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There is a long wait list for the drug including celebrities and well-known people.

    60% confidence
  • AI will cure all disease within a few years.

    60% confidence
  • People, including high-end doctors, venture capitalists and biohackers, are clamoring for the drug.

    60% confidence
  • Matt Cook initially had zero confidence the drug combination would work because it consists of two safe, generic, non-longevity drugs.

    60% confidence
  • 1 Generation blocks the systemic spread of aging in the bloodstream, reawakens the body's own repair mechanism and restores health and youth to multiple tissues.

    60% confidence
  • Conboy's microfluidic testing system lets researchers ask which molecules can keep tissue young even when bathed in old blood serum.

    60% confidence
  • 1 Generation allows human cells to remain young even in the presence of old people's blood serum.

    60% confidence
  • After taking the injections, Cook experienced a surprising sense of mental clarity.

    60% confidence
  • The first longevity therapeutic to work in the human body is here and it's actually working.

    60% confidence
  • Subjects reported a broad set of symptoms and improvements that doesn't match what either underlying drug is known to do.

    60% confidence
  • Whether the drug combination will work is unknown, but there is enthusiasm based on Conboy's track record; Gladden is both skeptical and optimistic.

    60% confidence
  • In the battle between old and young blood, old blood dominates.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Moves Into Devices, Security and Platforms: Physical AI Data, On-Device Compute and Agent Governance Drive a Late-October Product Wave
In late October 2026, vendors across hardware, enterprise software and security launched products built around AI moving out of the cloud and into devices, workflows and physical systems. Examples include NVIDIA RTX Spark laptops with Adobe, ASUS and Windows support for local and hybrid AI, and Harvest Praxis and Encord on embodied or physical AI. Enterprise software and security vendors (Salesforce–Braze, Fortinet, ServiceNow, Cisco, Intuit) are consolidating AI-driven customer data, adding inline AI security and agent governance, and embedding AI in financial and accounting workflows. The finance link is indirect: it rests on M&A, fintech-adjacent AI tooling and the capital flowing into physical AI. No regulatory driver appears in the facts.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,548 source documents archived
Query this data → isubstrate.com